Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis.

Lopez-Olivo MA, Negrón JB, Zogala RJ, Carmona L, Criner K, Goel N, Gonzalez-Lopez L, Ingegnoli F, Leong A, March L, Shea B, Strand V, Tugwell P, Westrich-Robertson T, Zamora NV, Christensen R, Suarez-Almazor ME.

J Rheumatol. 2019 Mar 1. pii: jrheum.181076. doi: 10.3899/jrheum.181076. [Epub ahead of print]

PMID:
30824644
2.

Lysyl oxidase-a possible role in systemic sclerosis-associated pulmonary hypertension: a multicentre study.

Vadasz Z, Balbir Gurman A, Meroni P, Farge D, Levi Y, Ingegnoli F, Braun-Moscovici Y, Rosner I, Slobodin G, Rozenbaum M, Jiries N, Kaly L, Boulman N, Zilber K, Ginsberg S, Awisat A, Goldberg Y, Lurie M, Ghigna MR, Guignabert C, Humbert M, Rimar D.

Rheumatology (Oxford). 2019 Feb 15. pii: kez035. doi: 10.1093/rheumatology/kez035. [Epub ahead of print]

PMID:
30770717
3.

Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report.

Pauling JD, Frech TM, Hughes M, Gordon JK, Domsic RT, Anderson ME, Ingegnoli F, McHugh NJ, Johnson SR, Hudson M, Boin F, Ong VH, Matucci-Cerinic M, Altorok N, Scolnik M, Nikpour M, Shah A, Pope JE, Khanna D, Herrick AL.

J Scleroderma Relat Disord. 2018 Oct;3(3):249-252. doi: 10.1177/2397198318774307. Epub 2018 May 24.

4.

Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis.

Ingegnoli F, Ughi N, Mihai C.

Best Pract Res Clin Rheumatol. 2018 Apr;32(2):223-240. doi: 10.1016/j.berh.2018.08.005. Epub 2018 Sep 14. Review.

PMID:
30527428
5.

Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.

Raschi E, Chighizola CB, Cesana L, Privitera D, Ingegnoli F, Mastaglio C, Meroni PL, Borghi MO.

Arthritis Res Ther. 2018 Aug 29;20(1):187. doi: 10.1186/s13075-018-1689-6.

6.

Evidence of macro- and micro-angiopathy in scleroderma: An integrated approach combining 22-MHz power Doppler ultrasonography and video-capillaroscopy.

Schioppo T, Orenti A, Boracchi P, De Lucia O, Murgo A, Ingegnoli F.

Microvasc Res. 2019 Mar;122:125-130. doi: 10.1016/j.mvr.2018.07.001. Epub 2018 Jul 6.

PMID:
29981761
7.

Anti-inflammatory Effect of Somatostatin Analogue Octreotide on Rheumatoid Arthritis Synoviocytes.

Casnici C, Lattuada D, Crotta K, Truzzi MC, Corradini C, Ingegnoli F, Tonna N, Bianco F, Marelli O.

Inflammation. 2018 Oct;41(5):1648-1660. doi: 10.1007/s10753-018-0808-5.

PMID:
29804189
8.

Acute and chronic effects of two different intravenous iloprost regimens in systemic sclerosis: a pragmatic non-randomized trial.

Schioppo T, Orenti A, Boracchi P, De Lucia O, Murgo A, Ingegnoli F.

Rheumatology (Oxford). 2018 Aug 1;57(8):1408-1416. doi: 10.1093/rheumatology/key113.

PMID:
29733400
9.

Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus.

Ingegnoli F, Schioppo T, Allanore Y, Caporali R, Colaci M, Distler O, Furst DE, Hunzelmann N, Iannone F, Khanna D, Matucci-Cerinic M.

Semin Arthritis Rheum. 2019 Feb;48(4):686-693. doi: 10.1016/j.semarthrit.2018.03.019. Epub 2018 Apr 4.

PMID:
29706243
10.

Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview.

Gualtierotti R, Parisi M, Ingegnoli F.

Adv Ther. 2018 Apr;35(4):439-456. doi: 10.1007/s12325-018-0686-0. Epub 2018 Mar 20. Review.

11.

The patient experience of Raynaud's phenomenon in systemic sclerosis.

Pauling JD, Saketkoo LA, Matucci-Cerinic M, Ingegnoli F, Khanna D.

Rheumatology (Oxford). 2019 Jan 1;58(1):18-26. doi: 10.1093/rheumatology/key026.

PMID:
29538754
12.

Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis.

Pauling JD, Domsic RT, Saketkoo LA, Almeida C, Withey J, Jay H, Frech TM, Ingegnoli F, Dures E, Robson J, McHugh NJ, Herrick AL, Matucci-Cerinic M, Khanna D, Hewlett S.

Arthritis Care Res (Hoboken). 2018 Sep;70(9):1373-1384. doi: 10.1002/acr.23475. Epub 2018 Aug 16.

13.

Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal.

Cutolo M, Melsens K, Wijnant S, Ingegnoli F, Thevissen K, De Keyser F, Decuman S, Müller-Ladner U, Piette Y, Riccieri V, Ughi N, Vandecasteele E, Vanhaecke A, Smith V.

Autoimmun Rev. 2018 Apr;17(4):344-352. doi: 10.1016/j.autrev.2017.11.025. Epub 2018 Feb 8. Review.

PMID:
29427827
14.

Reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseases.

Cutolo M, Melsens K, Herrick AL, Foeldvari I, Deschepper E, De Keyser F, Distler O, Ingegnoli F, Mostmans Y, Müller-Ladner U, Pizzorni C, Riccieri V, Ruaro B, Sulli A, Trombetta AC, Vanhaecke A, Smith V; EULAR Study Group on Microcirculation in Rheumatic Diseases.

Rheumatology (Oxford). 2018 Apr 1;57(4):757-759. doi: 10.1093/rheumatology/kex460. Review. No abstract available.

15.

Current perspective on rituximab in rheumatic diseases.

Schioppo T, Ingegnoli F.

Drug Des Devel Ther. 2017 Oct 3;11:2891-2904. doi: 10.2147/DDDT.S139248. eCollection 2017. Review.

16.

Serum chemerin in systemic sclerosis: a novel marker of early diffuse disease?

Chighizola CB, Raschi E, Privitera D, Luppino AF, Artusi C, Schioppo T, Mastaglio C, Ingegnoli F, Borghi MO, Meroni PL.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):223-224. Epub 2017 Sep 29. No abstract available.

PMID:
28980906
17.

Outcomes, rates and predictors of transition of isolated Raynaud's phenomenon: a systematic review and meta-analysis.

Ingegnoli F, Ughi N, Crotti C, Mosca M, Tani C.

Swiss Med Wkly. 2017 Sep 30;147:w14506. doi: 10.4414/smw.2017.14506. eCollection 2017. Review.

18.

Zenker Diverticulum in Systemic Sclerosis-Related Achalasic Megaesophagus.

Ingegnoli F, Schioppo T.

J Clin Rheumatol. 2017 Dec;23(8):444. doi: 10.1097/RHU.0000000000000597. No abstract available.

PMID:
28926464
19.

An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey).

Ingegnoli F, Ughi N, Dinsdale G, Orenti A, Boracchi P, Allanore Y, Foeldvari I, Sulli A, Cutolo M, Smith V, Herrick AL; EULAR Study Group on Microcirculation in RheumaticDiseases.

Rheumatol Int. 2017 Nov;37(11):1879-1890. doi: 10.1007/s00296-017-3808-0. Epub 2017 Sep 11.

PMID:
28894946
20.

Mapping and predicting mortality from systemic sclerosis.

Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airò P, Joven B, Vettori S, Cozzi F, Ullman S, Czirják L, Tikly M, Müller-Ladner U, Caramaschi P, Distler O, Iannone F, Ananieva LP, Hesselstrand R, Becvar R, Gabrielli A, Damjanov N, Salvador MJ, Riccieri V, Mihai C, Szücs G, Walker UA, Hunzelmann N, Martinovic D, Smith V, Müller CS, Montecucco CM, Opris D, Ingegnoli F, Vlachoyiannopoulos PG, Stamenkovic B, Rosato E, Heitmann S, Distler JHW, Zenone T, Seidel M, Vacca A, Langhe E, Novak S, Cutolo M, Mouthon L, Henes J, Chizzolini C, Mühlen CAV, Solanki K, Rednic S, Stamp L, Anic B, Santamaria VO, De Santis M, Yavuz S, Sifuentes-Giraldo WA, Chatelus E, Stork J, Laar JV, Loyo E, García de la Peña Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y; EUSTAR group.

Ann Rheum Dis. 2017 Nov;76(11):1897-1905. doi: 10.1136/annrheumdis-2017-211448. Epub 2017 Aug 23.

PMID:
28835464
21.

Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis.

Gualtierotti R, Ughi N, Marfia G, Ingegnoli F.

Rheumatol Ther. 2017 Dec;4(2):293-308. doi: 10.1007/s40744-017-0068-0. Epub 2017 Jul 27. Review.

22.

Corrigendum to "Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes [Semin Arthritis Rheum 46(5) (2017) 609-614].

Ingegnoli F, Carmona L, Castrejon I.

Semin Arthritis Rheum. 2017 Dec;47(3):e13. doi: 10.1016/j.semarthrit.2017.06.002. Epub 2017 Jul 1. No abstract available.

PMID:
28676176
23.

Capillaroscopy in Routine Diagnostics: Potentials and Limitations.

Ingegnoli F, Smith V, Sulli A, Cutolo M.

Curr Rheumatol Rev. 2018 Apr 20;14(1):5-11. doi: 10.2174/1573397113666170615084229. Review.

PMID:
28641553
24.

Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis.

Marzano AV, Raimondo MG, Berti E, Meroni PL, Ingegnoli F.

Clin Rev Allergy Immunol. 2017 Dec;53(3):428-438. doi: 10.1007/s12016-017-8616-5. Review.

PMID:
28578472
25.

Nailfold scleroderma-like capillary abnormalities in Werner syndrome (adult progeria).

Ingegnoli F, Crotti C.

Vasc Med. 2017 Jun;22(3):246-247. doi: 10.1177/1358863X17692667. Epub 2017 Mar 17. No abstract available.

PMID:
28466674
26.

Detection of early endothelial damage in patients with Raynaud's phenomenon.

Gualtierotti R, Ingegnoli F, Griffini S, Grovetti E, Borghi MO, Bucciarelli P, Meroni PL, Cugno M.

Microvasc Res. 2017 Sep;113:22-28. doi: 10.1016/j.mvr.2017.04.004. Epub 2017 Apr 25.

PMID:
28450106
27.

Feasibility, acceptability and construct validity of EQ-5D in systemic sclerosis.

Gualtierotti R, Ingegnoli F, Scalone L, Cortesi P, Bruschi E, Gerosa M, Meroni PL.

Swiss Med Wkly. 2016 Dec 19;146:w14394. doi: 10.4414/smw.2016.14394. eCollection 2016.

28.

Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes.

Ingegnoli F, Carmona L, Castrejon I.

Semin Arthritis Rheum. 2017 Apr;46(5):609-614. doi: 10.1016/j.semarthrit.2016.10.002. Epub 2016 Oct 13. Review. Erratum in: Semin Arthritis Rheum. 2017 Dec;47(3):e13.

PMID:
27839740
29.

The Adipose Mesenchymal Stem Cell Secretome Inhibits Inflammatory Responses of Microglia: Evidence for an Involvement of Sphingosine-1-Phosphate Signalling.

Marfia G, Navone SE, Hadi LA, Paroni M, Berno V, Beretta M, Gualtierotti R, Ingegnoli F, Levi V, Miozzo M, Geginat J, Fassina L, Rampini P, Tremolada C, Riboni L, Campanella R.

Stem Cells Dev. 2016 Jul 15;25(14):1095-107. doi: 10.1089/scd.2015.0268. Epub 2016 Jun 27.

PMID:
27217090
30.

Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockade.

Gualtierotti R, Ingegnoli F, Griffini S, Grovetti E, Meroni PL, Cugno M.

Clin Exp Rheumatol. 2016 May-Jun;34(3):451-8. Epub 2016 Apr 15.

PMID:
27086948
31.
32.

Smac127 Has Proapoptotic and Anti-Inflammatory Effects on Rheumatoid Arthritis Fibroblast-Like Synoviocytes.

Lattuada D, Gualtierotti R, Crotta K, Seneci P, Ingegnoli F, Corradini C, Viganò R, Marelli O, Casnici C.

Mediators Inflamm. 2016;2016:6905678. doi: 10.1155/2016/6905678. Epub 2016 Feb 17.

33.

An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases.

Smith V, Beeckman S, Herrick AL, Decuman S, Deschepper E, De Keyser F, Distler O, Foeldvari I, Ingegnoli F, Müller-Ladner U, Riccieri V, Riemekasten G, Sulli A, Voskuyl A, Cutolo M; EULAR study group on microcirculation.

Rheumatology (Oxford). 2016 May;55(5):883-90. doi: 10.1093/rheumatology/kev441. Epub 2016 Feb 3.

PMID:
26843483
34.

Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds.

Marfia G, Navone SE, Di Vito C, Ughi N, Tabano S, Miozzo M, Tremolada C, Bolla G, Crotti C, Ingegnoli F, Rampini P, Riboni L, Gualtierotti R, Campanella R.

Organogenesis. 2015;11(4):183-206. doi: 10.1080/15476278.2015.1126018. Review.

35.

Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis.

Gualtierotti R, Ingegnoli F, Two R, Meroni PL, Khanna D, Adorni G, Becciolini A, Ciavarella T, Marfia G, Murgo A, Scalone L, Ughi N, Zeni S; VERITAS study group.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S55-60. Epub 2015 Aug 31.

PMID:
26339890
36.

IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus.

Facciotti F, Gagliani N, Häringer B, Alfen JS, Penatti A, Maglie S, Paroni M, Iseppon A, Moro M, Crosti MC, Stölzel K, Romagnani C, Moroni G, Ingegnoli F, Torretta S, Pignataro L, Annoni A, Russo F, Pagani M, Abrignani S, Meroni P, Flavell R, Geginat J.

J Allergy Clin Immunol. 2016 Jan;137(1):318-321.e5. doi: 10.1016/j.jaci.2015.06.044. Epub 2015 Aug 25. No abstract available.

PMID:
26318071
37.

A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study.

Ingegnoli F, Boracchi P, Gualtierotti R, Smith V, Cutolo M, Foeldvari I; EUSTAR co-authors.

Microvasc Res. 2015 Nov;102:19-24. doi: 10.1016/j.mvr.2015.07.007. Epub 2015 Aug 4.

PMID:
26254260
38.

Uniphasic Blanching of the Fingers, Abnormal Capillaroscopy in Nonsymptomatic Digits, and Autoantibodies: Expanding Options to Increase the Level of Suspicion of Connective Tissue Diseases beyond the Classification of Raynaud's Phenomenon.

Ingegnoli F, Gualtierotti R, Orenti A, Schioppo T, Marfia G, Campanella R, Mastaglio C, Meroni PL, Boracchi P.

J Immunol Res. 2015;2015:371960. doi: 10.1155/2015/371960. Epub 2015 May 17.

39.

Sparing effect of hemiplegia on skin fibrosis and microvascular involvement: reports of two cases of systemic sclerosis and review of the literature.

Ughi N, Hervey SA, Gualtierotti R, Silvana Z, Herrick AL, Ingegnoli F, Meroni P.

Semin Arthritis Rheum. 2015 Apr;44(5):597-601. doi: 10.1016/j.semarthrit.2014.10.011. Epub 2014 Oct 29. Review.

PMID:
25488380
40.

Choroidal impairment and macular thinning in patients with systemic sclerosis: the acute study.

Ingegnoli F, Gualtierotti R, Pierro L, Del Turco C, Miserocchi E, Schioppo T, Meroni PL; ACUTE study group; ACUTE study group.

Microvasc Res. 2015 Jan;97:31-6. doi: 10.1016/j.mvr.2014.08.008. Epub 2014 Sep 26.

PMID:
25262916
41.

Proapoptotic activity of a monomeric smac mimetic on human fibroblast-like synoviocytes from patients with rheumatoid arthritis.

Lattuada D, Casnici C, Crotta K, Seneci PF, Corradini C, Truzzi M, Ingegnoli F, Marelli O.

Inflammation. 2015 Feb;38(1):102-9. doi: 10.1007/s10753-014-0012-1.

42.

Authors' reply to Verdelli et al.: there is no knowledge without experience.

Ingegnoli F, Tourlaki A, Gualtierotti R.

Clin Drug Investig. 2014 Jun;34(6):439. doi: 10.1007/s40261-014-0201-6. No abstract available.

PMID:
24811253
43.

Focus on the potential effects of treatments for spondylarthritides on cardiovascular risk.

Ingegnoli F, Gualtierotti R, Artusi C, Lubrano E.

Expert Rev Clin Immunol. 2014 Feb;10(2):307-15. doi: 10.1586/1744666X.2014.875468. Review.

PMID:
24410540
44.

Fibrosis biomarkers in isolated Raynaud's phenomenon: too little, too soon?

Ingegnoli F, Gualtierotti R, Schioppo T, Orenti A, Boracchi P, Lubatti C, Mastaglio C, Galbiati V, Murgo A, Zeni S, Grossi C, Borghi O, Rosenberg W, Castelnovo L, Meroni Pier L.

Ann Rheum Dis. 2014 May;73(5):940-1. doi: 10.1136/annrheumdis-2013-204009. Epub 2013 Dec 16. No abstract available.

PMID:
24344159
45.

Rheumatoid factors: clinical applications.

Ingegnoli F, Castelli R, Gualtierotti R.

Dis Markers. 2013;35(6):727-34. doi: 10.1155/2013/726598. Epub 2013 Nov 13. Review.

46.

Tocilizumab monotherapy in a patient with rheumatoid arthritis and iatrogenic Kaposi sarcoma.

Ingegnoli F, Tourlaki A, Gualtierotti R.

Clin Drug Investig. 2014 Feb;34(2):159-61. doi: 10.1007/s40261-013-0159-9.

PMID:
24307431
47.

Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study.

Ghrénassia E, Avouac J, Khanna D, Derk CT, Distler O, Suliman YA, Airo P, Carreira PE, Foti R, Granel B, Berezne A, Cabane J, Ingegnoli F, Rosato E, Caramaschi P, Hesselstrand R, Walker UA, Alegre-Sancho JJ, Zarrouk V, Agard C, Riccieri V, Schiopu E, Gladue H, Steen VD, Allanore Y.

J Rheumatol. 2014 Jan;41(1):99-105. doi: 10.3899/jrheum.130386. Epub 2013 Dec 1.

PMID:
24293584
48.

A systematic overview on the use and relevance of capillaroscopy in systemic sclerosis.

Ingegnoli F, Gualtierotti R.

Expert Rev Clin Immunol. 2013 Nov;9(11):1091-7. doi: 10.1586/1744666X.2013.849198. Epub 2013 Oct 22. Review.

PMID:
24147535
49.

Nailfold capillary patterns in healthy subjects: a real issue in capillaroscopy.

Ingegnoli F, Gualtierotti R, Lubatti C, Bertolazzi C, Gutierrez M, Boracchi P, Fornili M, De Angelis R.

Microvasc Res. 2013 Nov;90:90-5. doi: 10.1016/j.mvr.2013.07.001. Epub 2013 Jul 21.

PMID:
23880032
50.

Nailfold capillaroscopy in systemic sclerosis: data from the EULAR scleroderma trials and research (EUSTAR) database.

Ingegnoli F, Ardoino I, Boracchi P, Cutolo M; EUSTAR co-authors.

Microvasc Res. 2013 Sep;89:122-8. doi: 10.1016/j.mvr.2013.06.003. Epub 2013 Jun 17.

PMID:
23792167

Supplemental Content

Loading ...
Support Center